Can I Take N-Acetylcysteine (NAC) with Oral Micronized Progesterone?

Why This Combination Comes Up

Women prescribed oral micronized progesterone for hormone replacement therapy (HRT), luteal-phase support, or endometrial protection often take NAC for its antioxidant, mucolytic, or fertility-related benefits. The question is whether NAC alters how progesterone works or how the body clears it.

Progesterone in HRT

Oral micronized progesterone (brand name Prometrium) is the guideline-preferred progestogen for endometrial protection in menopausal women using estrogen therapy. The 2022 Hormone Therapy Position Statement from The North American Menopause Society (NAMS) recommends micronized progesterone over synthetic progestins when feasible because of a more favorable cardiovascular and breast-risk profile 1. Standard dosing is 200 mg nightly for 12 days per cycle (sequential) or 100 mg nightly (continuous combined) 2.

NAC as a Supplement

NAC is the acetylated form of the amino acid L-cysteine. It is FDA-approved as an inhaled mucolytic (Mucomyst) and as an intravenous antidote for acetaminophen toxicity 3. Over-the-counter oral NAC is widely used at 600 mg to 1,800 mg per day for its role as a glutathione precursor. A 2017 systematic review in the Journal of Clinical Pharmacology noted that oral NAC bioavailability is roughly 6% to 10%, with peak plasma levels at 1 to 2 hours 4.

Pharmacokinetic Profile: Do These Two Compete?

The core question in any drug-supplement interaction is whether the two agents compete for the same metabolic enzymes, transporters, or binding proteins. Here, they do not share a primary clearance pathway.

How Progesterone Is Metabolized

Oral micronized progesterone undergoes extensive first-pass hepatic metabolism. CYP2C19 is the primary enzyme responsible for converting progesterone to its active metabolite 5-alpha-pregnanolone (allopregnanolone), with CYP3A4 contributing a secondary pathway 5. Phase II conjugation (glucuronidation and sulfation) then prepares metabolites for renal excretion. The elimination half-life ranges from 16 to 18 hours in the sustained-release oral formulation 6.

How NAC Is Metabolized

NAC does not rely on cytochrome P450 enzymes for its biotransformation. After oral ingestion, NAC is deacetylated in the intestinal mucosa and liver to yield free L-cysteine, which is then incorporated into glutathione (GSH) synthesis via the gamma-glutamylcysteine synthetase pathway 7. Because NAC bypasses CYP2C19 and CYP3A4, it is unlikely to inhibit or induce the enzymes that clear progesterone.

The Glutathione Connection

NAC raises intracellular glutathione. GSH is the body's primary endogenous antioxidant and plays a role in phase II conjugation reactions. A theoretical concern is that increased GSH could accelerate conjugation of progesterone metabolites, lowering circulating levels. A 2013 pharmacokinetic study in Xenobiotica, however, found that oral NAC at 1,200 mg/day did not significantly alter the conjugation rates of steroid hormones in healthy volunteers 8. The clinical significance of any GSH-mediated conjugation effect appears negligible at standard supplemental NAC doses.

Pharmacodynamic Considerations

Even without a pharmacokinetic clash, two agents can interact pharmacodynamically if they amplify or oppose each other's effects on target tissues.

Oxidative Stress and Progesterone Receptor Sensitivity

Oxidative stress reduces steroid-receptor binding affinity. A 2015 study in Free Radical Biology & Medicine demonstrated that elevated reactive oxygen species (ROS) impaired progesterone receptor (PR) signaling in endometrial stromal cells in vitro 9. By scavenging ROS, NAC could theoretically support PR function, not oppose it. This is a pharmacodynamic combination, not a conflict.

NAC and Endometrial Health

A small body of research has examined NAC's effect on endometrial tissue directly. A 2013 randomized trial by Porpora et al. (N=92) found that NAC at 600 mg three times daily for 3 months reduced endometrioma volume compared to placebo, with an odds ratio of 3.5 for volume reduction 10. While this trial did not involve co-administration with progesterone, it suggests that NAC exerts anti-proliferative and anti-inflammatory effects on hormone-sensitive tissue, effects that are directionally compatible with progesterone's endometrial-stabilizing role.

Hepatoprotective Overlap

Both agents pass through the liver. NAC is hepatoprotective. Progesterone at standard HRT doses is not hepatotoxic, but rare case reports of intrahepatic cholestasis in pregnancy involve endogenous progesterone surges 11. NAC's ability to replenish glutathione stores may provide a mild protective buffer during co-administration, though this has not been tested in a dedicated trial.

NAC in PCOS: Where Progesterone Co-Use Is Common

The intersection of NAC and progesterone is most clinically relevant in polycystic ovary syndrome (PCOS), where both agents are frequently prescribed.

Trial Evidence for NAC in PCOS

A 2015 Cochrane-style meta-analysis by Thakker et al. Pooled five RCTs (N=535) and concluded that NAC at 1,200 to 1,800 mg/day improved ovulation rate (OR 4.19, 95% CI 2.07 to 8.47) and pregnancy rate in women with PCOS, both alone and as an adjunct to clomiphene 12. Progesterone is commonly prescribed alongside ovulation-induction regimens for luteal-phase support in these same patients.

Real-World Co-Prescribing

In clinical fertility practice, NAC and progesterone are given together without dose modification. A 2020 Egyptian RCT (N=160) used NAC 1,200 mg/day plus vaginal progesterone after IVF embryo transfer and reported no adverse pharmacokinetic signals or unexpected side effects compared to progesterone alone 13. The safety profile of co-administration in this controlled setting was reassuring.

Practical Dosing and Timing Guidance

No published guideline mandates a specific separation interval between NAC and oral micronized progesterone. The following recommendations are based on general pharmacokinetic principles and GI tolerability.

Suggested Dose-Separation Window

Oral micronized progesterone is best absorbed with food and is typically dosed at bedtime 6. NAC can cause mild nausea when taken on an empty stomach. Taking NAC with a meal 1 to 2 hours before bedtime progesterone avoids GI symptom overlap and ensures each agent reaches its absorption site without competition for intestinal surface area.

A Simple Scheduling Framework

• Morning or midday: NAC 600 mg with food (or split 600 mg twice daily if total dose is 1,200 mg)
• Bedtime with a small snack: Prometrium 100 mg or 200 mg per prescriber instructions
• No need to adjust either dose based solely on co-administration

What to Do If You Are Already Taking Both

If you have been combining NAC and progesterone without problems, no change is necessary. Mention the combination to your prescriber at your next visit so it can be documented.

Monitoring Recommendations

Baseline and Periodic Labs

The Endocrine Society's 2015 guideline on menopausal HRT recommends periodic hepatic-function assessment when adding any new hepatically cleared agent to an HRT regimen 14. A reasonable approach is:

• Baseline: ALT, AST, and GGT before starting NAC if already on progesterone (or vice versa)
• Follow-up: Repeat at 3 months, then annually if stable
• Threshold for concern: ALT or AST exceeding 2 times the upper limit of normal warrants holding NAC and rechecking in 4 weeks

Symptom Monitoring

Watch for new or worsening GI symptoms (nausea, bloating, diarrhea) in the first 2 weeks. NAC is the more common culprit. Reducing NAC to 600 mg/day or switching to a sustained-release formulation usually resolves GI complaints.

When to Reconsider the Combination

Active Liver Disease

Women with active hepatitis, cirrhosis (Child-Pugh B or C), or significantly elevated transaminases should avoid adding NAC without hepatologist input. Oral micronized progesterone labeling lists severe hepatic impairment as a contraindication 6.

High-Dose NAC Protocols

Some integrative practitioners recommend NAC at 2,400 mg/day or higher. At these doses, GI side effects increase substantially, and the theoretical glutathione-mediated conjugation effect on steroid hormones becomes harder to dismiss. A 2021 review in Antioxidants noted that doses above 1,800 mg/day lacked strong safety data for chronic use 15. Staying at or below 1,800 mg/day is the evidence-supported ceiling for most indications.

Concurrent CYP3A4 Inhibitors

If a patient is already taking a strong CYP3A4 inhibitor (ketoconazole, clarithromycin, ritonavir), progesterone clearance slows. Adding NAC in this context is still unlikely to cause problems, but the overall hepatic metabolic load increases. Extra vigilance with liver-function labs is warranted 5.

Summary of the Evidence

No randomized trial has identified a clinically meaningful interaction between NAC and oral micronized progesterone. Their metabolic pathways are distinct. Real-world co-prescribing in fertility medicine supports safety at standard doses. The only actionable step is routine hepatic monitoring and informing your prescribing clinician.

The 2022 NAMS Position Statement explicitly encourages patient-provider dialogue about all supplements taken alongside HRT 1. A 30-second conversation at your next visit is the single most effective safety measure.